The hearing, which commenced on Tuesday, 18 February, 2025, is being overseen by US Bankruptcy Judge Christopher Lopez in ...
Nearly six weeks after Johnson & Johnson paused the U.S. external evaluation of its Varipulse pulsed field ablation catheter ...
Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby ...
Mumbai: Bombay High Court has directed the immediate release of a woman along with her one-year-old child from Byculla ...
Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...
2d
Hosted on MSNJ&J Stock Up More Than 6% in a Month: Time to Buy, Sell or Hold?J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected ...
Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...
The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...
Volta Medical put forward new data showing its artificial-intelligence-guided ablation procedures were able to improve ...
A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...
Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results